Implications of the human immunodeficiency virus epidemic for control and eradication of measles

Clinical Infectious Diseases

Volumn 29, Issue 1, 1999, Pages 106-112

  Moss, William J ^a,b   Cutts, Felicity ^a,b   Griffin, Diane E ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; PNEUMONIA; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0032812676     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/520136     Document Type: Article

References (66)

1. 1. Centers for Disease Control and Prevention. Measles eradication: recommendations from a meeting cosponsored by the World Health Organization, the Pan American Health Organization, and CDC. MMWR Morb Mortal Wkly Rep 1997;46(RR-11):1-20.
2. 2. Centers for Disease Control and Prevention. Advances in global measles control and elimination: summary of the 1997 international meeting. MMWR Morb Mortal Wkly Rep 1998;47(RR-11):1-23.
3. 3. Enders JF, McCarthy K, Mitus A, Cheatham WJ. Isolation of measles virus at autopsy in cases of giant-cell pneumonia without rash. N Engl J Med 1959;261:875-81.
4. 4. Mitus A, Enders JF, Craig JM, Holloway A. Persistence of measles virus and depression of antibody formation in patients with giant cell pneumonia after measles. N Engl J Med 1959;261:882-9.
5. 5. Scheifele DW, Forbes CE. Prolonged giant cell excretion in severe African measles. Pediatrics 1972;50:867-73.
6. 6. Dossetor J, Whittle HC, Greenwood BM. Persistent measles infection in malnourished children. Br Med J 1977;1:1633-5.
7. 7. Centers for Disease Control. Measles in HIV-infected children, United States. MMWR Morb Mortal Wkly Rep 1988;37:183-6.
8. 8. Markowitz LE, Chandler FW, Roldan EO, et al. Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis 1988;158:480-3.
9. 9. Krasinski K, Borkowsky W. Measles and measles immunity in children infected with human immunodeficiency virus. JAMA 1989;261:2512-6.
10. 10. Chandwani, Kaul A, Dijohn D, et al. Measles infection and immunoprophylaxis failure in HIV-1 infected children [abstract no. 469]. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Chicago). Washington, DC: American Society for Microbiology, 1991.
11. 11. Nadel S, McGann K, Hodinka RL, Rutstein R, Chatten J. Measles giant cell pneumonia in a child with human immunodeficiency virus infection. Pediatr Infect Dis J 1991;10:542-4.
12. 12. Palumbo P, Hoyt L, Demasio K, Oleske J, Connor E. Population-based study of measles and measles immunization in human immunodeficiency virus infected children. Pediatr Infect Dis J 1992;11:1008-14.
13. 13. Rudy BJ, Rutstein RM, Pinto-Martin J. Response to measles immunization in children infected with human immunodeficiency virus. J Pediatr 1994;125:72-4.
14. 14. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992;267:1237-41.
15. 15. Ross LA, Kim KS, Gomperts E. Successful treatment of disseminated measles in a patient with acquired immunodeficiency syndrome: consideration of antiviral and passive immunotherapy. Am J Med 1990;88:313-4.
16. 16 Stogner SW, King JW, Black-Payne C, Bocchini J. Ribavirin and intravenous immune globulin therapy for measles pneumonia in HIV infection. South Med J 1993;86:1415-8.
17. 17. Forni AL, Schluger NW, Roberts RB. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis 1994;19:454-62.
18. 18. Bell JE, Lowrie S, Koffi K, et al. The neuropathology of HIV-infected African children in Abidjan, Cote d'Ivoire. J Neuropathol Exp Neurol 1997;56:686-92.
19. 19. Sharer LR, Fischer B, Blumberg BM, et al. Opportunistic measles virus infection of the CNS in children with AIDS [abstract no. P21-14]. Brain Pathol 1994;4:480.
20. 20. Vigliano P, Boffi P, Giordana MT, Tovo PA, Palomba E, Regardetto R. Subacute measles encephalitis in a boy with perinatal HIV-1 infection. Dev Med Child Neurol 1995;37:1117-9.
21. 21. Mustafa MM, Weitman SD, Winick NJ, Bellini WJ, Timmons CF, Siegel JD. Subacute measles encephalitis in the young immunocompromised host: report of two cases diagnosed by polymerase chain reaction and treated with ribavirin and review of the literature. Clin Infect Dis 1993;16:654-60.
22. 22. Budka H, Urbanits S, Liberski PP, Eichinger S, Popow-Kraupp T. Subacute measles virus encephalitis: a new and fatal opportunistic infection in a patient with AIDS. Neurology 1996;46:586-7.
23. 23. Koppel BS, Poon TP, Khandji A, Pavlakis SG, Pedley TA. Subacute sclerosing panencephalitis and acquired immunodeficiency syndrome: role of electroencephalography and magnetic resonance imaging. J Neuroimaging 1996;6:122-5.
24. 24. Ranganathan S, Poon T, Tchertkoff V. Subacute sclerosing panencephalitis(SSPE) in AIDS [abstract no. P21-13]. Brain Pathol 1994;4:480.
25. 25. Sharer LR, Dowling PC, Cook SD, Menonna J, Blumberg BM, Epstein LG. Spinal cord disease in children with HIV-1 infection: a combined molecular biological and neuropathological study. Neuropathol Appl Neurobiol 1990;16:317-31.
26. 26. Uylanco CV, Beroy GJ, Santiago LT, et al. A double-blind, placebo-controlled evaluation of ribavirin in the treatment of acute measles. Clin Ther 1981;3:389-96.
27. 27. Friedman S. Measles in New York City [letter]. JAMA 1991;266:1220.
28. 28. Diaz T, Nunez JC, Rullan JV, Markowitz LE, Barker ND, Horan J. Risk factors associated with severe measles in Puerto Rico. Pediatr Infect Dis J 1992;11:836-40.
29. 29. Sension MG, Quinn TC, Markowitz LE, et al. Measles in hospitalized African children with human immunodeficiency virus. Am J Dis Child 1988;142:1271-2.
30. 30. Oshitani H, Suzuki H, Mpabalwani ME, Mitzuta K, Numazaki Y. Measles case fatality by sex, vaccination status and HIV-1 antibody in Zambian children [letter]. Lancet 1996;348:415.
31. 31. Immunization Practices Advisory Committee (ACIP). Immunization of children infected with human immunodeficiency virus supplementary ACIP statement. MMWR Morb Mortal Wkly Rep 1988;37:181-6.
32. 32. Brena AE, Cooper ER, Cabral HJ, Pelton SI. Antibody response to measles and rubella vaccine by children with HIV infection. J Acquir Immune Defic Syndr 1993;6:1125-9.
33. 33. Frenkel LM, Nielsen K, Garakian A, Cherry JD. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med 1994;148:57-60.
34. 34. Brunell PA, Vimal V, Sandhu M, Courville TM, Daar E, Israele V. Abnormalities of measles antibody response in human immunodeficiency virus type 1 (HIV-1) infection. J Acquir Immune Defic Syndr Hum Retrovirol 1995;10:540-8.
35. 35. Arpadi SM, Markowitz LE, Baughman AL, et al. Measles antibody in vaccinated human immunodeficiency virus type 1-infected children. Pediatrics 1996;97:653-7.
36. 36. Ndikuyeze A, Taylor E, Farzadegan H, Polk HF. Measles immunization in children with human immunodeficiency virus infection [letter]. Vaccine 1987;5:168.
37. 37. Cernescu C, Constantinescu SN, Patrascu IV. Measles antibodies in HIV-1 infected children. Rev Roum Virol 1990;41:133-4.
38. 38. Molyneaux PJ, Mok JYQ, Burns SM, Yap PL. Measles, mumps, and rubella immunisation in children at risk of infection with human immunodeficiency virus. J Infect 1993;27:151-3.
39. 39. Walter EB, Katz SL, Bellini WJ. Measles immunity in HIV-infected children. Pediatr AIDS HIV Infect 1994;5:300-4.
40. 40. Jason J, Murphy J, Sleeper LA, et al. Immune and serologic profiles of HIV-infected and noninfected hemophilic children and adolescents. Am J Hematol 1994;46:29-35.
41. 41. Al-Attar I, Reisman J, Muchlmann M, McIntosh K. Decline of measles antibody titers after immunization in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1995;14:149-51.
42. 42. Embree J, Datta P, Stackiw W, et al. Increased risk of early measles in infants of human immunodeficiency virus type 1-seropositive mothers. J Infect Dis 1992;165:262-7.
43. 43. De Moraes-Pinto MI, Farhat CK, Carbonare SB, et al. Maternally acquired immunity in newborns from women infected by the human immunodeficiency virus. Acta Paediatr 1993;82:1034-8.
44. 44. De Moraes-Pinto, Almeida ACM, Kenj G, et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996;173:1077-84.
45. 45. Lepage P, Dabis F, Msellati P, et al. Safety and immunogenicity of high-dose Edmonston-Zagreb measles vaccine in children with HIV-1 infection. A cohort study in Kigali, Rwanda. Am J Dis Child 1992;146:550-5.
46. 46. Cutts FT, Mandala K, St Louis M, et al. Immunogenicity of high-titer Edmonston-Zagreb measles vaccine in human immunodeficiency virus-infected children in Kinshasa, Zaire. J Infect Dis 1993;167:1418-21.
47. 47. Garenne M, Leroy O, Beau JP, Sene I. Child mortality after high-titre measles vaccines: prospective study in Senegal. Lancet 1991;338:903-7.
48. 48. Sprauer MA, Markowitz LE, Nicholson JKA, et al. Response of human immunodeficiency virus infected adults to measles-rubella vaccination. J Acquir Immune Defic Syndr 1993;6:1013-6.
49. 49. Wallace MR, Hooper DG, Graves SJ, Malone JL. Measles seroprevalence and vaccine response in HIV-1 infected adults. Vaccine 1994;12:1222-4.
50. 50. Sha BE, Harris AA, Benson CA, et al. Prevalence of measles antibodies in asymptomatic human immunodeficiency virus-infected adults. J Infect Dis 1991;164:973-5.
51. 51. Kemper CA, Zolopa AR, Hamilton JR, Fenstersheib M, Bhatia G, Deresinski SC. Prevalence of measles antibodies in adults with HIV infection: possible risk factors for measles seronegativity. AIDS 1992;6:1321-5.
52. 52. Glaser JB, DeCorato DR, Greifinger R. Measles antibody status of HIV-1 infected prison inmates. J Acquir Immune Defic Syndr 1991;4:540-1.
53. 53. Glaser JB, Greifinger R. Measles antibodies in human immunodeficiency virus-infected adults. J Infect Dis 1992;165:589-90.
54. 54. Clark RA, Dlamini G, Brandon W, Wisniewski T. Immunity to measles and rubella in women infected with human immunodeficiency virus [letter]. Clin Infect Dis 1992;15:739.
55. 55. Zolopa AR, Kemper CA, Shiboski S, Hamilton JR, Moss AR, Deresinski SC. Progressive immunodeficiency due to infection with human immunodeficiency virus does not lead to waning immunity to measles in a cohort of homosexual men. Clin Infect Dis 1994;18:636-8.
56. 56. Kemper CA, Gangar M, Arias G, Kane C, Deresinski SC. The prevalence of measles antibody in human immunodeficiency virus-infected patients in northern California. J Infect Dis 1998;178:1177-80.
57. 57. Halsey NA, Henderson DA. HIV infection and immunization against other agents. N Engl J Med 1987;316:683-5.
58. 58. von Reyn CF, Clements CJ, Mann JM. Human immunodeficiency virus infection and routine childhood immunisation. Lancet 1987;2:669-72.
59. 59. Onorato IM, Markowitz LE, Oxtoby MJ. Childhood immunization, vaccine-preventable diseases, and infection with human immunodeficiency virus. Pediatr Infect Dis 1988;7:588-95.
60. 60. Onorato IM, Orenstein WA, Hinman AR. Immunization of asymptomatic HIV-infected children with measles vaccine: assessment of risks and benefits. Med Decis Making 1989;9:76-83.
61. 61. McLaughlin M, Thomas P, Onorato I, et al. Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. Pediatrics 1988;82:229-33.
62. 62. Centers for Disease Control and Prevention. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993. MMWR Morb Mortal Wkly Rep 1996;45:603-6.
63. 63. Angel JB, Walpita P, Lerch RA, et al. Vaccine-associate measles pneumonitis in an adults with AIDS. Ann Intern Med 1998;129:104-6.
64. 64. Centers for Disease Control and Prevention. Measles, mumps and rubella - vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998;47(RR-8):1-22.
65. 65. Nicholson JKA, Holman RC, Jones BM, McDougal JS, Sprauer MA, Markowitz LE. The effect of measles-rubella vaccination on lymphocyte populations and subpopulations in HIV-infected and healthy individuals. J Acquir Immune Defic Syndr 1992;5:528-9.
66. 66. Baskar PV, Collins GD, Dorsey-Cooper BA, et al. Serum antibodies to HIV-1 are produced post-measles virus infection: evidence for cross-reactivity with HLA. Clin Exp Immunol 1998;111:251-6.